Skip to content

Pacific Biosciences of California PACB Revenue recognized that was included in deferred income at the beginning of the period

Discontinued — last reported Q3 '22

Revenue recognized that was included in deferred income at the beginning of the period at other companies

HTF
Heartflow, Inc. Common StockHTFL
$89K+166%
Paycom Software logo
Paycom SoftwarePAYC
$9M-5.3%
AMC Networks Inc. logo
AMC Networks Inc.AMCX
$19.1M-5.0%
ePlus logo
ePlusPLUS
$24M+57.9%
APO
Apogee EnterprisesAPOG
$115K+360%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$7.9M+204%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.

The official record: Pacific Biosciences of California’s 10-Q, filed November 8, 2022, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's revenue recognized that was included in deferred income at the beginning of the period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's revenue recognized that was included in deferred income at the beginning of the period?
Pacific Biosciences of California (PACB) reported revenue recognized that was included in deferred income at the beginning of the period of $2.3M in Q3 2022.